Relapsed/Refractory Large B-cell Lymphoma Clinical Trials

13 clinical trials for Relapsed/Refractory Large B-cell Lymphoma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma. — RECRUITING · PHASE1
• Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with a Glofitamab-based induction and consolidation concept — RECRUITING · PHASE2
• A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma — RECRUITING · PHASE1
• MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma — RECRUITING · PHASE2
• Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL — RECRUITING · PHASE2
• GLORY: Glofit-GemOx With Liso-Cel For Lymphoma — NOT_YET_RECRUITING · PHASE2
• Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL — NOT_YET_RECRUITING · PHASE2
• Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy — TERMINATED · PHASE2
• Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma — COMPLETED · PHASE1
• Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma — TERMINATED · PHASE2
• Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma — TERMINATED · PHASE1
• Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma — TERMINATED · PHASE1

Refine this search